Clinical Research Directory
Browse clinical research sites, groups, and studies.
Surgery Versus Biologics for Stricturing CD--a RCT
Sponsor: Zhu Weiming
Summary
The management of stricturing Crohn's disease (CD) remains challenging. Although surgical resection may be the final way to solve it, the efficacy of biologics for symptomatic CD associated strictures was acceptable. In clinical practice, the chioce of treatment is particularly difficult. Therefore, a clinical trial of biologics versus surgery is needed to assess which one is prefered.
Official title: Surgical Intervention Versus Biologics Treatment for Symptomatic Stricturing Crohn's Disease (SIBTC): an Open-label, Single-center, Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
138
Start Date
2022-06-09
Completion Date
2030-06
Last Updated
2022-07-13
Healthy Volunteers
No
Conditions
Interventions
Group A
treat participants with biologics
Group B
treat participants with surgery
Locations (1)
Department of General Surgery, Jinling hosptal,Medical School of Nanjing University
Nanjing, Jiangsu, China